On Thursday, Bluebird Bio Inc. (NASDAQ:BLUE) reported a third-quarter EPS loss of 31 cents, compared to a loss of 80 cents a ...

On Friday, bluebird bio Inc (BLUE) stock saw a decline, ending the day at $0.32 which represents a decrease of $-0.04 or -11.11% from the prior close of $0.36. The stock opened at $0.37 and touched a ...

(BLUE) stock downgraded by Bank of America and J.P. Morgan after the company's Q3 2024 results. Read more here.

Bluebird Bio's Q3 EPS loss was 31 cents ... per quarter and obtains additional cash resources to extend its runway. JP Morgan downgraded Bluebird after the third-quarter results.

JP Morgan downgraded Bluebird after the third-quarter ... In September, Bluebird bio implemented a restructuring to optimize its cost structure and enable quarterly cash flow break-even in the ...

Analyst Eric Joseph of J.P. Morgan maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report), retaining the price target of ...

On Thursday, bluebird bio Inc (BLUE) stock saw a decline, ending the day at $0.36 which represents a decrease of $-0.02 or -5.26% from the prior close of $0.38. The stock opened at $0.37 and touched a ...

In celebration of its 100th year as an institution open to the public, the Morgan Library and Museum has launched the ...

J.P. Morgan analyst Eric Joseph maintained a Sell rating on Novavax ... Joseph covers the Healthcare sector, focusing on stocks such as Bluebird Bio, Wave Life Sciences, and Novavax. TipRanks tracks ...

JP Morgan Chase analysts say they’re ‘not surprised’ sector has come ‘under pressure’ since Kennedy’s nomination ...